Short Term Action

NovoRapid^® - The rapid acting insulin of choice

Safe

• Significantly reduces risk of major nocturnal hypoglycaemia by 72%¹ Read more
• Demonstrates long-term safety² Read more

Effective

• Provides effective basal-bolus treatment with Levemir^3,4 Read more
• Limited or no weight gain^3-5 Read more

Flexible

• Flexibility in mealtime dosing^6,7 Read more
• Available in FlexPen^® – preferred by people with diabetes⁸ Read more